Hemispherx BioPharma Inc. (HEB) rose 8.82% or 0.05 to $0.57. It is approximately 2.55 million shares traded, which is 268.37% compare to the average total volume 950949. The market cap of HEB is $18.24 million. The year to date change is 52.43%. The 52 week price range is from $0.3 to $0.93. Price of HEB have changed 21.18% during last week. It have changed 69.65% over last month, 59.36% over last 3 months, 10.53% over last 6 months and -35.79% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.35. It is -38.60% below current price. The 200-day Moving Averages for HEB is 0.43. It is -24.56% below current price. The 52-week High is 0.93. It is 63.16% from the current price. The 52-week Low is 0.3. It is -47.37% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of HEB is 1.4 on 2017-12-29. Short % to float is 3.73%. There are some statistics of HEB. It is has market cap $18.24 million. The share outstanding is 31.87 million. The average volume is 950949. The percent of top 15 Institution holding is 8.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -55.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -40.99%.